Vedanta Q1 FY27 Results Analysis: Revenue Surges 53.6%, EBITDA Margin Expands 800 bps (VEDL)

CompoundingAI Research Updated July 31, 2026 2 min read
Positive

Vedanta Ltd's Q1 FY27 numbers came in strong, with revenue of Rs. 24,205.00 Cr (+53.60% YoY) and PAT growth of +151.90% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateJuly 30, 2026
QuarterQ1 FY 2026-2027
Revenue (Q1)Rs. 24,205.00 Cr (+53.60% YoY)
PAT (Q1)Rs. 5,294.00 Cr (+151.90% YoY)
EBITDA margin35.10% (+800 bps YoY)
Market capRs. 104,602.88 Cr
CMPRs. 267.50

Quarter Snapshot

Vedanta's Q1 FY27 shows strong growth in continuing operations, with revenue up 53.6% YoY and EBITDA margin expanding 800 bps to 35.1%, led by the Zinc India segment's 62.4% margin. The demerger has structurally improved the balance sheet, halving finance costs, while the CRISIL rating upgrade and MoPNG approval for oil & gas asset transfer add positive catalysts. However, promoter share sale and high encumbrance, along with regulatory observations on related party transactions, warrant monitoring.

Key Investment Insights

Key Positives

  • Revenue from continuing operations grew 53.6% YoY to Rs.24,205 Cr
  • EBITDA margin expanded 800 bps YoY to 35.1%
  • PAT from continuing operations grew 151.9% YoY to Rs.5,294 Cr
  • Zinc, Lead & Silver segment achieved EBITDA margin of 62.4%
  • Interest Service Coverage Ratio improved to 12.59x from 8.52x in Q4
  • CRISIL upgraded long-term rating to AA+/Stable post-quarter

Risk Factors

  • Copper segment EBITDA margin remains negligible at 0.1%
  • Promoter holding reduced from 40.02% to 38.35% via share sale
  • Promoter encumbrance at 54.72% of shares under a US$2.25B facility
  • SEBI observations on HZL's related party transactions (approvals and disclosure aspects)
  • ED conducted FEMA search at company premises in June; no further communication received
Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.

Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings

Login Now